Navigation Links
Student, 16, invents new drug cocktail to fight cystic fibrosis, wins Canadian biotech challenge
Date:5/10/2011

Fort Richmond Collegiate, Winnipeg, who combined the standard drug treatment for leukaemia with a lung cancer drug to greatly increase the numbers of leukemia cells being killed.

14 truly cutting-edge biotechnology projects

On Monday, remarkable students from every province presented the judges with 14 truly cutting-edge biotechnology projects related to health, agriculture and the environment. All were previous prize-winners at regional SABC competitions held across Canada in April.

All 13 to 19 years old and enrolled in Grades 9 through 12, the students were mentored by university professors and others who volunteer their expertise and many hours over several months each year to assist these young researchers.

How a 16-year-old used a supercomputer to find a promising new treatment for cystic fibrosis

Grade 11 student Marshall Zhang impressed many experts when he used the Canadian SCINET supercomputing network to discover a new and potentially effective drug cocktail to treat cystic fibrosis.

The results demonstrated the usefulness of computer-based approaches to discover drug-like compounds.

"Marshall's findings show that computational methods can drive the discovery of compounds that may offer effective treatment for cystic fibrosis," says his project mentor Dr. Christine Bear, a researcher at the Hospital for Sick Children's Research Institute.

CF is a common genetic disease where the lungs' normal protective coating of thin mucus becomes thick and sticky -- an inviting environment for serious, sometimes fatal bacterial infections. A genetic mutation is responsible for most cases of CF. Leading research currently in clinical trials suggests that specific drugs may help correct this defect.

At Dr. Bear's lab at Sick Kids, Marshall used sophisticated SCINET computer modeling to investigate what these drugs might be doing to 'correct' the genetic defect at the mole
'/>"/>

Contact: Terry Collins
tc@tca.tc
416-538-8712
Bioscience Education Canada
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. University of Nevada, Reno invents next-gen device to track worlds air quality
2. NJIT licensee invents industrial process for grinding cement and other cementitious materials
3. Purdue researcher invents molecule that stops SARS
4. Host change alters toxic cocktail
5. MicroRNA cocktail helps turn skin cells into stem cells
6. Chemical cocktail affects humans and the environment
7. Plasma produces KO cocktail for MRSA
8. Powerful nutrient cocktail can put kids with Crohns into remission
9. Skip this cocktail party
10. Parsley, celery carry crucial component for fight against breast cancer, MU researcher finds
11. Hitting target in cancer fight now easier with new nanoparticle platform, UCLA scientists say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/2/2015)... 2, 2015 At its 2015 ACMG Annual ... , the American College of Medical Genetics and ... to its Board.  Members of the ACMG Board of ... forming and advancing its policies and programs. ACMG is ... "It,s an eventful time in medical genetics and ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... of California, San Diego bioengineering professor Trey Idekera ... Society for Computational Biology,s Overton Prize. The Overton ... scientist who has already made a significant contribution ... Ideker is an Associate Professor of Bioengineering at ...
... National biobanks play a vital role in modern health research ... data, but they are expensive to run. Can we make ... borders on a larger scale? This is the theme of ... How can we maximize the value and use of ...
... A study to determine if patients with type 2 ... self-donated) stem cell infusions (ASC) and hyperbaric (above the ... and after ASC has found "significant benefits" in terms ... requirements." The combination therapy could decrease type 2 diabetes ...
Cached Biology News:UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize 2UC San Diego bioengineering professor trey ideker wins 2009 Overton Prize 3Harmonizing biobank research: An achievable world-wide goal 2Stem cell infusion and hyperbaric oxygen treatment improve islet function in diabetes 2
(Date:5/5/2015)... 2015  Indianapolis-based medical device manufacturer NICO Corporation ... of products including the BrainPath® and Myriad™ technologies ... brain abnormalities and then removing affected tissue. More ... than 50 institutions throughout the United ... included in 12 abstracts, three peer-reviewed publications, and ...
(Date:5/4/2015)... , May 4, 2015 Many of ... But for certain infants with rare, inherited mutations ... stark consequences of their impaired immune responses. ... have identified an important role for calcium signaling ... Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... MEMPHIS, Tenn. , May 4, 2015 /PRNewswire-USNewswire/ ... have developed a significantly better computer tool for ... in many cancers but were difficult to identify ... the scientific journal Nature Methods . ... short for Copy Number Segmentation by Regression Tree ...
(Date:5/4/2015)... STONY BROOK, N.Y. , May 4, 2015 ... executed a $250,000 cooperative research and development agreement ... ) to advance the development of TRB-N0224 for ... companion animals, including dogs and cats.  Traverse Biosciences ... sublicense TRB-N0224 for the treatment and control of ...
Breaking Biology Technology:NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Scientists dramatically improve method for finding common genetic alterations in tumors 2Scientists dramatically improve method for finding common genetic alterations in tumors 3Scientists dramatically improve method for finding common genetic alterations in tumors 4Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4
... , SEATTLE, Sept. 18 Omeros Corporation today ... million shares of its common stock. Omeros is a ... focused on inflammation and disorders of the central nervous system. ... the initial public offering is $10.00 to $12.00 per share. ...
... , EMERYVILLE, Calif., Sept. 17 ... today that, on September 15, 2009, it received a letter ... of NTI,s common stock has closed below $1.00 per share ... closing bid price below $1.00 per share is a deficiency ...
... , , EAST HANOVER, ... has approved Valturna(R) (aliskiren and valsartan) tablets, the first and only ... known as the renin angiotensin aldosterone system (RAAS), an important regulator ... is indicated for the treatment of high blood pressure in patients ...
Cached Biology Technology:Omeros Commences Initial Public Offering of Common Stock 2Omeros Commences Initial Public Offering of Common Stock 3Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification 2Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 2Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 3Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 4Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 5Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 6Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure 7
mitochondrial proteins (human heart) for SDS-polyacrylamide gel electrophoresis *2 mg/mL*...
... GeneMaths XT is undoubtedly the most complete ... advanced concept of layers and subsets makes ... layers for different data outputs, for example ... etc., as well as different subsets of ...
...
...
Biology Products: